The latest price target for Oncorus Inc rdinary Shares (OTC:ONCR) was reported by HC Wainwright & Co. on December 6, 2022. The analyst firm set a price target for $0.00 expecting ONCR to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

The latest analyst rating for Oncorus Inc rdinary Shares (OTC:ONCR) was provided by HC Wainwright & Co., and Oncorus Inc rdinary Shares downgraded their neutral rating.

There is no last upgrade for Oncorus Inc rdinary Shares

The last downgrade for Oncorus Inc rdinary Shares happened on December 6, 2022 when HC Wainwright & Co. changed their price target from N/A to N/A for Oncorus Inc rdinary Shares.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Oncorus Inc rdinary Shares, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Oncorus Inc rdinary Shares was filed on December 6, 2022 so you should expect the next rating to be made available sometime around December 6, 2023.

While ratings are subjective and will change, the latest Oncorus Inc rdinary Shares (ONCR) rating was a downgraded with a price target of $0.00 to $0.00. The current price Oncorus Inc rdinary Shares (ONCR) is trading at is $0.13, which is out of the analyst’s predicted range.